Segall Bryant & Hamill LLC Buys 6,789 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Segall Bryant & Hamill LLC increased its stake in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 139,391 shares of the company's stock after acquiring an additional 6,789 shares during the period. Segall Bryant & Hamill LLC owned about 0.45% of iRhythm Technologies worth $12,569,000 as of its most recent SEC filing.

• Top 3 Robotics and Automation Stocks for the Next AI Boom

Other institutional investors also recently bought and sold shares of the company. Intech Investment Management LLC bought a new stake in iRhythm Technologies in the third quarter valued at approximately $702,000. Charles Schwab Investment Management Inc. raised its holdings in iRhythm Technologies by 1.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 255,703 shares of the company's stock valued at $18,983,000 after buying an additional 4,173 shares during the last quarter. Algert Global LLC grew its holdings in iRhythm Technologies by 332.8% in the 3rd quarter. Algert Global LLC now owns 13,560 shares of the company's stock worth $1,007,000 after acquiring an additional 10,427 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of iRhythm Technologies in the third quarter valued at about $1,497,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of iRhythm Technologies by 7.3% during the third quarter. The Manufacturers Life Insurance Company now owns 196,423 shares of the company's stock valued at $14,582,000 after acquiring an additional 13,377 shares during the last quarter.

Analyst Ratings Changes

IRTC has been the topic of a number of research analyst reports. Canaccord Genuity Group boosted their price target on iRhythm Technologies from $125.00 to $152.00 and gave the company a "buy" rating in a report on Monday, December 9th. Wells Fargo & Company upped their target price on iRhythm Technologies from $86.00 to $104.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. Truist Financial lifted their price target on shares of iRhythm Technologies from $111.00 to $145.00 and gave the company a "buy" rating in a report on Friday, February 21st. Oppenheimer raised their target price on shares of iRhythm Technologies from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 8th. Finally, Needham & Company LLC lifted their target price on shares of iRhythm Technologies from $125.00 to $138.00 and gave the company a "buy" rating in a research note on Friday, February 21st. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, iRhythm Technologies has an average rating of "Moderate Buy" and an average target price of $119.73.

• 4 Stocks With Huge Cash Holdings at Silicon Valley Bank

Get Our Latest Report on iRhythm Technologies

iRhythm Technologies Stock Up 0.7 %

IRTC stock opened at $106.60 on Wednesday. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00. The business has a 50 day moving average of $108.14 and a 200 day moving average of $89.47. iRhythm Technologies, Inc. has a twelve month low of $55.92 and a twelve month high of $128.52. The firm has a market cap of $3.35 billion, a PE ratio of -29.29 and a beta of 1.36.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.30. The firm had revenue of $164.33 million during the quarter, compared to analyst estimates of $158.30 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. On average, research analysts forecast that iRhythm Technologies, Inc. will post -1.98 EPS for the current fiscal year.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

Read More

• Five stocks we like better than iRhythm Technologies
• Investing in Construction Stocks
• Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
• P/E Ratio Calculation: How to Assess Stocks
• NVIDIA Insiders Sell: This Is What It Means for the Market
• Stock Trading Terms - Stock Terms Every Investor Needs to Know
• Space Stocks Bottoming: Which Are Positioned Best for a Bounce?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in iRhythm Technologies Right Now?

Before you consider iRhythm Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRhythm Technologies wasn't on the list.

While iRhythm Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here